|Year : 2020 | Volume
| Issue : 1 | Page : 69-72
Role of core-needle biopsies in cases of mediastinal mass lesions as a primary diagnostic modality in comparison with fine-needle aspiration cytology
Deepika Phogat, Venkatesan Manu, Ritu Mehta
Department of Pathology, INHS Asvini, Mumbai, Maharashtra, India
|Date of Submission||11-Apr-2019|
|Date of Decision||16-Dec-2019|
|Date of Acceptance||12-Jan-2020|
|Date of Web Publication||03-Mar-2020|
Major Deepika Phogat
Department of Pathology, INHS Asvini, Colaba, Mumbai, Maharashtra
Source of Support: None, Conflict of Interest: None
Introduction: The spectrum of mediastinal masses comprises of lesions of various origins. Although the clinicoradiological findings and the location of these lesions within different mediastinal compartments help narrow down the differentials, tissue diagnosis remains the gold standard for diagnosis. The image-guided percutaneous transthoracic fine-needle aspiration cytology (FNAC) and/or core-needle biopsy (CNB) of the mediastinal lesions are considered to be cost-effective and safe diagnostic procedures. CNB of mediastinal lesions is found to provide better yield with the accuracy of 75%–90% and is more precise as compared to FNAC. In this article, we study the role of CNB in cases of mediastinal masses as a primary diagnostic modality as compared to FNAC. Materials and Methods: A retrospective observational study was conducted at a tertiary care hospital in Mumbai. All cases with mediastinal mass lesions diagnosed by FNAC and/or CNB over a period of 1 year in a tertiary care hospital were analyzed. Cases were divided into FNAC group or CNB group depending on the primary diagnostic procedure undertaken. Comparisons were made between the two groups. Results: CNB group was found to have better diagnostic yield in benign as well as malignant lesions in comparison with the FNAC group. The time taken to reach the definitive diagnosis was found to be shorter in the CNB group as compared to the FNAC group. Conclusion: The use of CNB as a primary diagnostic modality may provide faster and accurate tissue diagnosis in cases of mediastinal masses of both benign and malignant nature as compared to FNAC.
Keywords: Computed tomography-guided biopsy, core-needle biopsy, fine-needle aspiration cytology, mediastinal masses, tissue diagnosis
|How to cite this article:|
Phogat D, Manu V, Mehta R. Role of core-needle biopsies in cases of mediastinal mass lesions as a primary diagnostic modality in comparison with fine-needle aspiration cytology. J Mar Med Soc 2020;22:69-72
|How to cite this URL:|
Phogat D, Manu V, Mehta R. Role of core-needle biopsies in cases of mediastinal mass lesions as a primary diagnostic modality in comparison with fine-needle aspiration cytology. J Mar Med Soc [serial online] 2020 [cited 2020 Apr 7];22:69-72. Available from: http://www.marinemedicalsociety.in/text.asp?2020/22/1/69/279874
| Introduction|| |
The wide spectrum of various benign and malignant lesions presenting as mediastinal masses poses a diagnostic challenge for pulmonologists, radiologists, and pathologists. Although clinical evaluation, imaging findings, and location of these lesions as per various compartments provide clue to differential diagnosis, accurate and reliable tissue diagnostic procedures are the gold standard and facilitate timely management of these lesions. The percutaneous transthoracic fine-needle aspiration cytology (FNAC) and/or core-needle biopsy (CNB) of the mediastinal lesions when performed under image guidance are minimally invasive, cost-effective, and safe diagnostic procedures. Excluding contraindications, the image-guided transthoracic CNB of mediastinal lesions is found to provide better yield with higher accuracy ranging from 75% to 99%,,, and is more precise as compared to FNAC., In this article, we study the role of image-guided transthoracic CNBs in cases of mediastinal masses as a primary diagnostic modality as compared to FNAC.
| Materials and Methods|| |
A retrospective observational study was conducted at a tertiary care hospital in Mumbai over a period of 1 year from January 2018 to December 2018. All cases with mediastinal mass lesions diagnosed by transthoracic computed tomography (CT)-guided FNAC and/or CNB over a period of 1 year were included in the study. Cases diagnosed by endoscopic Ultrasonography (USG)-guided transbronchial biopsy, open biopsy, thoracoscopy, or mediastinoscopy biopsy were excluded. Institutional ethics committee consent was obtained. The choice of procedure was made by the treating physician/surgeon in consultation with pathologist and radiologist after considering patients' age, clinical condition, and location of the lesion. In all cases, FNAC/CNB were performed by experienced pathologists and radiologists following standard protocol after patient workup. Written informed consent was obtained from the patients before the procedure.
Transthoracic approach was used under the guidance of CT scan. FNAC was done using 22–24G needle. Smears were air dried and wet fixed (95% alcohol). Cytology smears were prepared and stained by Leishman and Papanicolaou stains.
Core-needle biopsies were performed using a 14- or 16-G semiautomated cut needle to obtain histological tissue. The biopsy tissues were fixed in 10% formalin, processed, and embedded in paraffin; 4-μ thin sections were cut and stained by hematoxylin and eosin stain.
There were no procedure-related complications noted in any of the cases.
Cases were divided into FNAC group or CNB group depending on the primary diagnostic procedure undertaken.
Comparisons were made between the two groups according to parameters in the form of the nature of lesions diagnosed (benign/malignant), sample adequacy for diagnosis, repeat procedures done to achieve definitive diagnosis, and time taken to reach definitive diagnosis since the time of doing the procedure [Table 1].
| Results|| |
A total of 11 cases of mediastinal lesions underwent CT-guided transthoracic FNAC/CNB comprising 6 (54%) males and 5 (45%) females with the mean age of 46 years (range: 21–76 years). Most of the lesions were situated in the posterior mediastinum (5; 45%) and anterior mediastinum (5; 45%), followed by superior mediastinum. Six (54%) lesions were malignant as compared to 5 (45%) that were benign [Table 1]. In 6 (54%) cases, FNAC was done as the primary diagnostic procedure, of which only 2 (33%) cases yielded adequate smears for evaluation [Table 2]. The rest of the 4 (67%) cases had to undergo subsequent CNB to reach the definitive diagnosis. Two (33%) lesions that yielded smears adequate for evaluation were malignant in nature: One being a lymphoma and the other a metastatic deposit from adenocarcinoma [Figure 1]a and [Figure 1]b. Both these lesions also required subsequent confirmation on CNB with immunohistochemistry. Among the cases that were diagnosed on CNB, 5 (55%) cases were of malignant nature, whereas 4 (45%) were benign. In 5 (45%) cases out of 11 cases, CNB was performed as a primary procedure (without a prior FNAC) and definitive diagnosis could be achieved in all the 5 (100%) cases.
|Table 2: Comparison between core-needle biopsy and fine-needle aspiration cytology procedure|
Click here to view
|Figure 1: (a) Non-Hodgkin lymphoma on fine-needle aspiration cytology (left) (Pap stain, 40×) and core-needle biopsy (right) (H and E stain, 40×). (b) Metastatic adenocarcinoma on fine-needle aspiration cytology (left) (Leishman stain, 40×) and core-needle biopsy (right) (H and E stain, 40×)|
Click here to view
The time to achieve final diagnosis was recorded as the number of days taken to achieve the final definitive diagnosis following the primary diagnostic procedure (CNB/FNAC). The delay in report in the FNAC group was due to suboptimal cellular yield and subsequent biopsy procedures [Figure 2] and [Table 2].
|Figure 2: Mature cystic teratoma (left) and ganglioneuroma (middle) diagnosed with core-needle biopsy (H and E stain, 40×); fine-needle aspiration cytology with suboptimal cellular yield in these cases (right) (Leishman stain, 40×)|
Click here to view
Our study found that diagnostic yield was higher in the CNB group as compared to the FNAC group as primary diagnostic procedure [Table 3]a and [Table 3]b. The time to reach diagnosis was found to be considerably less in cases where CNB was done as a primary diagnostic procedure when compared to FNAC [Figure 3].
|Figure 3: Time taken to achieve the final diagnosis in the fine-needle aspiration cytology group and core-needle biopsy group|
Click here to view
| Discussion|| |
Mediastinal mass lesions have a wide spectrum of differential diagnosis. They could be neoplastic, nonneoplastic, benign, malignant, primary, or metastatic in nature. The treatment modalities vary according to the nature of lesions. Early diagnosis is important as these lesions expand inside the mediastinum and can cause damage to adjacent vital structures. The diagnosis requires an integrated clinical, radiological, and histological approach.
CT is the most important imaging tool in the evaluation of mediastinal mass lesions and is superior to USG. High-resolution CT images have very high levels of noise (due to thin sections and high-resolution algorithm), which may make them nondiagnostic for the soft tissues of the mediastinum.,
The percutaneous transthoracic CT-guided CNB/FNAC are minimally invasive procedures that help provide definitive diagnosis for these lesions.
Sensitivity and specificity of CNB is found to be higher than that of FNAC.,,,
Our study found better diagnostic yield and high concordance rate with CNB as compared to FNAC when performed as a primary diagnostic procedure. This is in concordance with studies by Protopapas and Westcott, Nasit et al., and Adler et al.,,
The time to achieve definitive diagnosis was less in CNB as compared to FNAC. This is in concordance with the study by Protopapas and Westcott, Adler et al., and Tscheikuna et al.,, These studies found CT-guided transthoracic CNB as a safe and accurate diagnostic procedure that decreases the number of inpatient days. CT-guided transthoracic CNB should be the first invasive diagnostic procedure in patients with mediastinal mass lesions.
The most common reason for inconclusive result of FNAC in these cases was suboptimal cellularity. Other reasons were obscuring with haemorrhage and drying/crushing artefacts. This is in concordance with the findings of the study by Nasit et al.
Limitations of the study
This study is limited by a small sample size; still, conclusion can be drawn as the cases show equal distribution in malignant and benign categories and an even gender and age distribution. Findings are concurrent with other studies done on these lesions as cited. The conclusion of this study may prove beneficial to patients with mediastinal lesions in terms of cost and patient safety. It may help in formulating an early and definitive diagnosis by instituting CT-guided transthoracic CNB as the primary diagnostic procedure which will help in early treatment.
| Conclusion|| |
Mediastinal mass lesions comprise of various neoplastic and non-neoplastic lesions requiring different treatment modalities. Early diagnosis is important as the lesions can cause damage to adjacent vital structures within the mediastinal compartment.
CT-guided transthoracic CNB when performed as a primary diagnostic procedure in cases of mediastinal lesions has been found to be a safe, cost-effective, time-saving, and definitive diagnostic procedure with higher yield and higher rate of conclusive, concordant results with minimal requirement for repeat invasive procedures. FNAC is often limited by inadequate sample and requires subsequent biopsy procedures for confirmation.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Dixit R, Shah NS, Goyal M, Patil CB, Panjabi M, Gupta RC, et al
. Diagnostic evaluation of mediastinal lesions: Analysis of 144 cases. Lung India 2017;34:341-8.
] [Full text]
Zafar N, Moinuddin S. Mediastinal needle biopsy. A 15-year experience with 139 cases. Cancer 1995;76:1065-8.
Protopapas Z, Westcott JL. Transthoracic hilar and mediastinal biopsy. Radiol Clin North Am 2000;38:281-91.
Wiersema MJ, Vazquez-Sequeiros E, Wiersema LM. Evaluation of mediastinal lymphadenopathy with endoscopic US-guided fine-needle aspiration biopsy. Radiology 2001;219:252-7.
Gupta S, Seaberg K, Wallace MJ, Madoff DC, Morello FA Jr., Ahrar K, et al
. Imaging-guided percutaneous biopsy of mediastinal lesions: Different approaches and anatomic considerations. Radiographics 2005;25:763-86.
Nasit JG, Patel M, Parikh B, Shah M, Davara K. Anterior mediastinal masses: A study of 50 cases by fine needle aspiration cytology and core needle biopsy as a diagnostic procedure. South Asian J Cancer 2013;2:7-13.
] [Full text]
Saha D, Deb J. Diagnostic role of ultra sound and computed tomography guided fine-needle aspiration cytology and Tru-cut biopsy experienced in 50 adult patients of mediastinal diseases. J Assoc Chest Phys 2015;3:48.
Kaur H, Tiwari P, Dugg P, Ghuman J, Shivhare P, S Mehmi R. Computed tomographic evaluation of mediastinal masses/lesions with contrast enhancement and correlation with pathological diagnosis – a study of 120 cases. Journal of Biomedical Graphics and Computing. 2014;4(3).
Takahashi K, Al-Janabi NJ. Computed tomography and magnetic resonance imaging of mediastinal tumors. J Magn Reson Imaging 2010;32:1325-39.
Adler OB, Rosenberger A, Peleg H. Fine-needle aspiration biopsy of mediastinal masses: Evaluation of 136 experiences. AJR Am J Roentgenol 1983;140:893-6.
Tscheikuna J, Suttinont P. Is cytology necessary in diagnosis of mediastinal mass? J Med Assoc Thai 2009;92 Suppl 2:S24-9.
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2], [Table 3]